• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞生长抑制剂 6-(杂芳基)-7-脱氮嘌呤核苷的环磷酰基磷酸核苷:合成、细胞生长抑制活性和对腺嘌呤激酶的抑制作用。

CycloSal-phosphate pronucleotides of cytostatic 6-(Het)aryl-7-deazapurine ribonucleosides: Synthesis, cytostatic activity, and inhibition of adenosine kinases.

机构信息

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.

出版信息

ChemMedChem. 2010 Aug 2;5(8):1386-96. doi: 10.1002/cmdc.201000192.

DOI:10.1002/cmdc.201000192
PMID:20533504
Abstract

A series of cycloSal-phosphate prodrugs of a recently described new class of nucleoside cytostatics (6-hetaryl-7-deazapurine ribonucleosides) was prepared. The corresponding 2',3'-isopropylidene 6-chloro-7-deazapurine nucleosides were converted into 5-O'-cycloSal-phosphates. These underwent a series of Stille or Suzuki cross-couplings with diverse (het)arylstannanes or -boronic acids to yield the protected 6-(het)aryl-7-deazapurine pronucleotides that were subsequently deprotected to give 12 derivatives of free pronucleotides. The in vitro cytostatic effect of the pronucleotides was compared with parent nucleoside analogues. In most cases, the activity of the pronucleotide was similar to or somewhat lower than that of the corresponding parent nucleosides, with the exception of 7-fluoro pronucleotides 13 a, 13 b, and 13 d, which had exhibited GIC(50) values that were improved by one order of magnitude (to the low nanomolar range). The presence of a cycloSal-phosphate group also influenced selectivity toward various cell lines. Several pronucleotides were found which strongly inhibit human adenosine kinase but only weakly inhibit the MTB adenosine kinase.

摘要

我们合成了一系列最近新描述的核苷类抗肿瘤药物(6-杂芳基-7-脱氮嘌呤核苷)的环磷酰基前药。相应的 2',3'-异亚丙基 6-氯-7-脱氮嘌呤核苷被转化为 5-O'-环磷酰基。这些经过一系列 Stille 或 Suzuki 交叉偶联反应,与不同的(杂)芳基锡烷或硼酸反应,得到保护的 6-(杂)芳基-7-脱氮嘌呤前核苷,然后脱保护得到 12 个游离前核苷衍生物。前核苷的体外细胞毒性作用与母体核苷类似物进行了比较。在大多数情况下,前核苷的活性与相应的母体核苷相似或略低,除了 7-氟前核苷 13a、13b 和 13d,它们的 GIC(50) 值提高了一个数量级(达到低纳摩尔范围)。环磷酰基的存在也影响了对各种细胞系的选择性。发现了几种前核苷,它们强烈抑制人腺苷激酶,但对 MTB 腺苷激酶的抑制作用较弱。

相似文献

1
CycloSal-phosphate pronucleotides of cytostatic 6-(Het)aryl-7-deazapurine ribonucleosides: Synthesis, cytostatic activity, and inhibition of adenosine kinases.细胞生长抑制剂 6-(杂芳基)-7-脱氮嘌呤核苷的环磷酰基磷酸核苷:合成、细胞生长抑制活性和对腺嘌呤激酶的抑制作用。
ChemMedChem. 2010 Aug 2;5(8):1386-96. doi: 10.1002/cmdc.201000192.
2
6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents.6-(杂芳基)7-脱氮嘌呤核苷作为新型有效的细胞生长抑制剂。
J Med Chem. 2010 Jan 14;53(1):460-70. doi: 10.1021/jm901428k.
3
Phosphoramidate pronucleotides of cytostatic 6-aryl-7-deazapurine ribonucleosides.具有细胞毒性的 6-芳基-7-脱氮嘌呤核苷的膦酰胺酯前体核苷酸。
Bioorg Med Chem. 2011 Jan 1;19(1):229-42. doi: 10.1016/j.bmc.2010.11.029. Epub 2010 Dec 4.
4
Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides.6-取代的 7-(杂)芳基-7-去氮嘌呤核苷的合成、细胞毒活性、抗微生物活性和抗 HCV 活性。
J Med Chem. 2014 Feb 13;57(3):1097-110. doi: 10.1021/jm4018948. Epub 2014 Jan 16.
5
2-Substituted 6-(Het)aryl-7-deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity.2-取代 6-(杂芳基)-7-脱氮嘌呤核苷:合成、腺苷激酶抑制和抗分枝杆菌活性。
ChemMedChem. 2015 Jun;10(6):1079-93. doi: 10.1002/cmdc.201500081. Epub 2015 Apr 16.
6
Synthesis and cytostatic and antiviral activities of 2'-deoxy-2',2'-difluororibo- and 2'-deoxy-2'-fluororibonucleosides derived from 7-(Het)aryl-7-deazaadenines.7-(杂芳基)-7-脱氮嘌呤核苷类化合物的合成及细胞毒和抗病毒活性。
ChemMedChem. 2013 May;8(5):832-46. doi: 10.1002/cmdc.201300047. Epub 2013 Apr 4.
7
Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4'-C-methylribonucleosides.6-或7-(杂)芳基-7-脱氮嘌呤4'-C-甲基核糖核苷的合成与生物学分析
Bioorg Med Chem. 2015 Dec 1;23(23):7422-38. doi: 10.1016/j.bmc.2015.10.040. Epub 2015 Oct 31.
8
Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: synthesis and evaluation of 6-substituted purine l-ribonucleosides.细胞生长抑制和抗病毒的6-芳基嘌呤核糖核苷。第7部分:6-取代嘌呤1-核糖核苷的合成与评价。
Bioorg Med Chem Lett. 2006 Oct 15;16(20):5290-3. doi: 10.1016/j.bmcl.2006.07.092. Epub 2006 Aug 14.
9
Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides.细胞生长抑制剂6-芳基嘌呤核苷。6. 一系列6-杂芳基嘌呤核糖核苷在抗丙型肝炎病毒及细胞生长抑制活性方面的构效关系。
J Med Chem. 2005 Sep 8;48(18):5869-73. doi: 10.1021/jm050335x.
10
Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.7-杂芳基-7-脱氮腺苷的合成及显著的细胞抑制活性。
J Med Chem. 2011 Aug 11;54(15):5498-507. doi: 10.1021/jm2005173. Epub 2011 Jul 11.

引用本文的文献

1
Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Therapy.脱氧核糖核酸甲基化中的腺苷激酶:治疗中不依赖腺苷受体的途径
Front Pharmacol. 2022 Jun 1;13:908882. doi: 10.3389/fphar.2022.908882. eCollection 2022.
2
Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.吡咯并[2,3-d]嘧啶(7-脱氮嘌呤)作为抗肿瘤和抗病毒核苷设计中的优势骨架。
Med Res Rev. 2017 Nov;37(6):1429-1460. doi: 10.1002/med.21465. Epub 2017 Aug 23.
3
Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy.
使用磷酸泛酸替代疗法纠正泛酸激酶1的基因缺陷。
Mol Genet Metab. 2015 Dec;116(4):281-8. doi: 10.1016/j.ymgme.2015.10.011. Epub 2015 Oct 29.
4
Synthesis of nucleoside phosphate and phosphonate prodrugs.核苷磷酸酯和膦酸酯前药的合成。
Chem Rev. 2014 Sep 24;114(18):9154-218. doi: 10.1021/cr5002035. Epub 2014 Aug 21.
5
Adenosine kinase: exploitation for therapeutic gain.腺嘌呤激酶:为治疗增益而进行的开发。
Pharmacol Rev. 2013 Apr 16;65(3):906-43. doi: 10.1124/pr.112.006361. Print 2013 Jul.